Clinical Trials on III 期 1 级滤泡性淋巴瘤 in Singapore
总计1个结果
-
National Cancer Institute (NCI)主动，不招人复发性 1 级滤泡性淋巴瘤 | 复发性 2 级滤泡性淋巴瘤 | 复发性 3 级滤泡性淋巴瘤 | 难治性滤泡性淋巴瘤 | 3a 级滤泡性淋巴瘤美国, 加拿大, 新加坡
此页面是自动翻译的，不保证翻译的准确性。请参阅 英文版 对于源文本。
赞助者和合作者
- Aummune Ltd.
- Association de Recherche Experimentale et Clinique en Chirurgie Digestive
- National Innovation Agency (NIA)
- Tina Vilsboll
- Oxford Cannabinoid Technologies Holdings PLC
- Karabuk University
- Hospira, now a wholly owned subsidiary of Pfizer
- AMILI Pte. Ltd.
- Ruhr University of Bochum, Bochum, Germany
- NeuroEM Therapeutics, Inc.
- Lundbech Foundation
- Bladder Cancer Canada
- Nyanza Western Kenya LGBTI Coalition
- Hercules
- Terveystalo
- Klavs Würgler Hansen
- Kaya, Guner, M.D.
- Yazeed Sawalha
- Sewon Cellontech Co., Ltd.
- Azienda Ospedaliera Pugliese Ciaccio
- 查看完整清单
CROs by country
- Contract Research Organizations in Argentina
- Contract Research Organizations in Austria
- Contract Research Organizations in Cyprus
- Contract Research Organizations in Denmark
- Contract Research Organizations in Djibouti
- Contract Research Organizations in Ethiopia
- Contract Research Organizations in Finland
- Contract Research Organizations in Georgia
- Contract Research Organizations in Kenya
- Contract Research Organizations in Malaysia
- Contract Research Organizations in Myanmar
- Contract Research Organizations in Portugal
- Contract Research Organizations in Spain
- CRO list by country